Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous mesenchymal stem cells (Belarusian Medical Academy of Post-Graduate Education)
- Development stage
- Unknown
- Lead developer
- Belarusian Medical Academy of Postgraduate Education
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intranasal
01
Overview
This is an investigational autologous cell therapy being developed by the Belarusian Medical Academy of Postgraduate Education for the treatment of Parkinson's disease. The therapy utilizes the patient's own mesenchymal stem cells (MSCs), which are harvested, processed, and then re-administered to the patient. The treatment aims to influence the pathogenesis of Parkinson's disease through multiple mechanisms, including potential neuroprotection and immunomodulation. Clinical evaluation involves two primary administration routes: a systemic intravenous method and a tandem approach combining intranasal delivery to the olfactory epithelium with intravenous infusion. The therapy is specifically being studied for its efficacy in managing both motor and non-motor symptoms in patients with rapidly progressive Parkinson's disease.
- Other names
- autologous mesenchymal stem cellsautologous MSCsautologous MMSC
Beyond the preview
Go deeper on autologous mesenchymal stem cells (Belarusian Medical Academy of Post-Graduate Education).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous mesenchymal stem cells (Belarusian Medical Academy of Post-Graduate Education).